M2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling
Lee, Woo Je, Tateya, Sanshiro, Cheng, Andrew M, Rizzo-DeLeon, Norma, Wang, Nicholas F, Handa, Priya, Wilson, Carole L, Clowes, Alexander W, Sweet, Ian R, Bomsztyk, Karol, Schwartz, Michael W, Kim, Francis
Published in Diabetes (New York, N.Y.) (01.08.2015)
Published in Diabetes (New York, N.Y.) (01.08.2015)
Get full text
Journal Article
Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells
Iwata, Naomi G, Pham, Matilda, Rizzo, Norma O, Cheng, Andrew M, Maloney, Ezekiel, Kim, Francis
Published in PloS one (28.12.2011)
Published in PloS one (28.12.2011)
Get full text
Journal Article
Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid rafts
Cheng, Andrew M, Handa, Priya, Tateya, Sanshiro, Schwartz, Jay, Tang, Chongren, Mitra, Poulami, Oram, John F, Chait, Alan, Kim, Francis
Published in PloS one (30.03.2012)
Published in PloS one (30.03.2012)
Get full text
Journal Article
The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression
Tateya, Sanshiro, Rizzo-De Leon, Norma, Cheng, Andrew M, Dick, Brian P, Lee, Woo Je, Kim, Madeleine L, O'Brien, Kevin, Morton, Gregory J, Schwartz, Michael W, Kim, Francis
Published in PloS one (24.04.2019)
Published in PloS one (24.04.2019)
Get full text
Journal Article
Reduced Vascular Nitric Oxide–cGMP Signaling Contributes to Adipose Tissue Inflammation During High-Fat Feeding
Handa, Priya, Tateya, Sanshiro, Rizzo, Norma O, Cheng, Andrew M, Morgan-Stevenson, Vicki, Han, Chang-Yeop, Clowes, Alexander W, Daum, Guenter, OʼBrien, Kevin D, Schwartz, Michael W, Chait, Alan, Kim, Francis
Published in Arteriosclerosis, thrombosis, and vascular biology (01.12.2011)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.12.2011)
Get full text
Journal Article
Vasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance
Cheng, Andrew M, Rizzo-DeLeon, Norma, Wilson, Carole L, Lee, Woo Je, Tateya, Sanshiro, Clowes, Alexander W, Schwartz, Michael W, Kim, Francis
Published in American journal of physiology: endocrinology and metabolism (01.10.2014)
Published in American journal of physiology: endocrinology and metabolism (01.10.2014)
Get full text
Journal Article
Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding
Tateya, Sanshiro, Rizzo, Norma O, Handa, Priya, Cheng, Andrew M, Morgan-Stevenson, Vicki, Daum, Guenter, Clowes, Alexander W, Morton, Gregory J, Schwartz, Michael W, Kim, Francis
Published in Diabetes (New York, N.Y.) (01.11.2011)
Published in Diabetes (New York, N.Y.) (01.11.2011)
Get full text
Journal Article
VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
TATEYA, Sanshiro, RIZZO-DE LEON, Norma, CHAIT, Alan, KIM, Francis, HANDA, Priya, CHENG, Andrew M, MORGAN-STEVENSON, Vicki, OGIMOTO, Kayoko, KANTER, Jenny E, BORNFELDT, Karin E, DAUM, Guenter, CLOWES, Alexander W
Published in Diabetes (New York, N.Y.) (01.06.2013)
Published in Diabetes (New York, N.Y.) (01.06.2013)
Get full text
Journal Article
The role of vasodilator-stimulated phosphoprotein
Tateya, Sanshiro, Rizzo-De Leon, Norma, Cheng, Andrew M, Dick, Brian P, Lee, Woo Je, Kim, Madeleine L, O'Brien, Kevin, Morton, Gregory J, Schwartz, Michael W, Kim, Francis
Published in PloS one (24.04.2019)
Published in PloS one (24.04.2019)
Get full text
Journal Article
Apolipoprotein A-I Attenuates Palmitate-Mediated NF-[kappa]B Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
Cheng, Andrew M, Handa, Priya, Tateya, Sanshiro, Schwartz, Jay, Tang, Chongren, Mitra, Poulami, Oram, John F, Chait, Alan, Kim, Francis
Published in PloS one (30.03.2012)
Published in PloS one (30.03.2012)
Get full text
Journal Article
Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
TATEYA, Sanshiro, RIZZO, Norma O, HANDA, Priya, CHENG, Andrew M, MORGAN-STEVENSON, Vicki, DAUM, Guenter, CLOWES, Alexander W, MORTON, Gregory J, SCHWARTZ, Michael W, KIM, Francis
Published in Diabetes (New York, N.Y.) (2011)
Get full text
Published in Diabetes (New York, N.Y.) (2011)
Journal Article
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study
Squires, Kathleen, Kityo, Cissy, Hodder, Sally, Johnson, Margaret, Voronin, Evgeny, Hagins, Debbie, Avihingsanon, Anchalee, Koenig, Ellen, Jiang, Shuping, White, Kirsten, Cheng, Andrew, Szwarcberg, Javier, Cao, Huyen
Published in The lancet HIV (01.09.2016)
Published in The lancet HIV (01.09.2016)
Get more information
Journal Article
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial
Sax, Paul E, DeJesus, Edwin, Crofoot, Gordon, Ward, Douglas, Benson, Paul, Dretler, Robin, Mills, Anthony, Brinson, Cynthia, Peloquin, Julie, Wei, Xuelian, White, Kirsten, Cheng, Andrew, Martin, Hal, Quirk, Erin
Published in The lancet HIV (01.04.2017)
Published in The lancet HIV (01.04.2017)
Get more information
Journal Article
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Orkin, Chloe, DeJesus, Edwin, Ramgopal, Moti, Crofoot, Gordon, Ruane, Peter, LaMarca, Anthony, Mills, Anthony, Vandercam, Bernard, de Wet, Joseph, Rockstroh, Jürgen, Lazzarin, Adriano, Rijnders, Bart, Podzamczer, Daniel, Thalme, Anders, Stoeckle, Marcel, Porter, Danielle, Liu, Hui C, Cheng, Andrew, Quirk, Erin, SenGupta, Devi, Cao, Huyen
Published in The lancet HIV (01.05.2017)
Published in The lancet HIV (01.05.2017)
Get more information
Journal Article
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
Sax, Paul E, Dr Prof, Wohl, David, MD, Yin, Michael T, Prof, Post, Frank, MD, DeJesus, Edwin, MD, Saag, Michael, MD, Pozniak, Anton, MD, Thompson, Melanie, MD, Podzamczer, Daniel, MD, Molina, Jean Michel, Prof, Oka, Shinichi, MD, Koenig, Ellen, MD, Trottier, Benoit, MD, Andrade-Villanueva, Jaime, MD, Crofoot, Gordon, MD, Custodio, Joseph M, PharmD, Plummer, Andrew, MS, Zhong, Lijie, PhD, Cao, Huyen, MD, Martin, Hal, MD, Callebaut, Christian, PhD, Cheng, Andrew K, MD, Fordyce, Marshall W, MD, McCallister, Scott, MD
Published in The Lancet (British edition) (27.06.2015)
Published in The Lancet (British edition) (27.06.2015)
Get full text
Journal Article
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
Sax, Paul E, Dr, DeJesus, Edwin, MD, Mills, Anthony, MD, Zolopa, Andrew, Prof, Cohen, Calvin, MD, Wohl, David, MD, Gallant, Joel E, Prof, Liu, Hui C, PhD, Zhong, Lijie, PhD, Yale, Kitty, BA, White, Kirsten, PhD, Kearney, Brian P, Pharm D, Szwarcberg, Javier, MD, Quirk, Erin, MD, Cheng, Andrew K, MD
Published in The Lancet (British edition) (30.06.2012)
Published in The Lancet (British edition) (30.06.2012)
Get full text
Journal Article
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
DeJesus, Edwin, Rockstroh, Jürgen K, MD, Henry, Keith, MD, Molina, Jean-Michel, MD, Gathe, Joseph, MD, Ramanathan, Srinivasan, PhD, Wei, Xuelian, PhD, Yale, Kitty, MSc, Szwarcberg, Javier, MD, White, Kirsten, Prof, Cheng, Andrew K, MD, Kearney, Brian P, Prof
Published in The Lancet (British edition) (30.06.2012)
Published in The Lancet (British edition) (30.06.2012)
Get full text
Journal Article
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Mills, Anthony, MD, Arribas, Jose R, MD, Andrade-Villanueva, Jaime, Prof, DiPerri, Giovanni, MD, Van Lunzen, Jan, Prof, Koenig, Ellen, MD, Elion, Richard, MD, Cavassini, Matthias, MD, Madruga, Jose Valdez, MD, Brunetta, Jason, MD, Shamblaw, David, MD, DeJesus, Edwin, MD, Orkin, Chloe, MBBch, Wohl, David A, MD, Brar, Indira, MD, Stephens, Jeffrey L, MD, Girard, Pierre-Marie, Prof, Huhn, Gregory, MD, Plummer, Andrew, BS, Liu, Ya-Pei, PhD, Cheng, Andrew K, MD, McCallister, Scott, Dr
Published in The Lancet infectious diseases (01.01.2016)
Published in The Lancet infectious diseases (01.01.2016)
Get full text
Journal Article
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
DeJesus, Edwin, Ramgopal, Moti, Crofoot, Gordon, Ruane, Peter, LaMarca, Anthony, Mills, Anthony, Martorell, Claudia T, de Wet, Joseph, Stellbrink, Hans-Jürgen, Molina, Jean-Michel, Post, Frank A, Valero, Ignacio Pérez, Porter, Danielle, Liu, YaPei, Cheng, Andrew, Quirk, Erin, SenGupta, Devi, Cao, Huyen
Published in The lancet HIV (01.05.2017)
Published in The lancet HIV (01.05.2017)
Get more information
Journal Article